EGCG reducing the susceptibility to cholesterol gallstone formation through the regulation of inflammation

Biomedicine and Pharmacotherapy

Volumn 62, Issue 10, 2008, Pages 677-683

  Shan, Dongmei ^a   Fang, Yishi ^a   Ye, Yiyi ^a   Liu, Jianwen ^a,b  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

( ) Epigallocatechin 3 gallate (EGCG); Anti inflammation effect; Cholesterol gallstone; Cholesterol metabolic

Indexed keywords

CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; EPIGALLOCATECHIN GALLATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL STONE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOWN REGULATION; DRUG EFFECT; FEMALE; INFLAMMATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATECHIN; CHOLECYSTITIS; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; DISEASE SUSCEPTIBILITY; FEMALE; GALLSTONES; GENE EXPRESSION PROFILING; LIPID PEROXIDATION; LIPIDS; LIVER; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 56049093249     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.12.008     Document Type: Article

References (25)

1. Singh A.K., Levenson R.B., Gervais D.A., Hahn P.F., Kandarpa K., and Mueller P.R. Dropped gallstones and surgical clips after cholecystectomy: CT assessment. J Comput Assist Tomogr 31 (2007) 758-762
2. Kurguzov O.P. Cholelithic small bowel obstruction. Khirurgiia (Mosk) (2007) 13-19
3. Jurriaan P., Danielle R.M., Dirk L., Dirk L.K., Albert B.B., and Gerrit V.D.W. Waiting for elective surgery: effect on physical problems and postoperative recovery. ANZ J Surg 77 (2007) 892-898
4. Portincasa P., Moschetta A., and Palasciano G. Cholesterol gallstone disease. Lancet 368 (2006) 230-239
5. Snijman P.W., Swanevelder S., Joubert E., and Green I.R. The antimutagenic activity of the major flavonoids of rooibos (Aspalathus linearis): some dose-response effects on mutagen activation-flavonoid interactions. Mutat Res 631 (2007) 111-123
6. Zhang Q., Wei D.Z., and Liu J.W. In vivo reversal of doxorubicin resistance by (-)-epigallocatechin-3-gallate in a solid human carcinoma xenograft. Cancer Lett 208 (2004) 179-186
7. Wei D.Z., Mei Y.Y., and Liu J.W. Quantification of doxorubicin and validation of reversal effect of tea polyphenols on multidrug resistance in human carcinoma cells. Biotechnol Lett 25 (2003) 291-294
8. Wang D.Q.-H., Paigen B., and Carey M.C. Phenotypic characterization of Lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice: physical-chemistry of gallbladder bile. J Lipid Res 38 (1997) 1395-1411
9. Ohkawa H., Oshishi N., and Yagi K. Assay of lipidperoxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
10. Hofmann A.F., Amelsberg A., and Vansonnenberg E. Pathogenesis and treatment of gallstones. N Engl J Med 328 (1993) 1854-1855
11. Diehl A.K. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 20 (1991) 1-19
12. Chiang JYL. Regulation of bile acid synthesis. Front Biosci [chapter 3].
13. Lyons M.A., and Wittenburg H. Susceptibility to cholesterol gallstones formation: evidence that LITH genes also encode immune-related factors. Biochim Biophys Acta 1761 (2006) 1133-1147
14. Wu Y.H., Zhou C.X., Li X.P., Song L.Y., Wu X.M., Lin W.Y., et al. Evaluation of anti-inflammatory activity of the total flavonoids of Laggera pterodonta on acute and chronic inflammation models. Phytother Res 20 (2006) 585-590
15. Paigen B., and Carey M.C. The genetic basis of common diseases (2002), Oxford University Press p. 298-335
16. Feingold K.R., Hardardottir I., Memon R., Krul E.J., and Moser A.H. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res 34 (1993) 2147-2158
17. Feingold K.R., Soued M., Serio M.K., and Moser A.H. Multiple cytokines stimulate hepatic lipid synthesis in vivo. Endocrinology 125 (1989) 267-274
18. Feingold K.R., Spady D.K., Pollock A.S., Moser A.H., and Grunfeld C. Endotoxin, TNF, and IL-1 decrease cholesterol 7α-hydroxylase mRNA levels and activity. J Lipid Res 37 (1996) 223-228
19. Xiao Z.L., Amaral J., Biancani P., and Behar J. Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones. Am J Physiol Gastrointest Liver Physiol 288 (2005) 525-532
20. Zen Y., Harada K., Sasaki M., Tsuneyama K., Katayanagi K., and Yamamoto Y. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 161 (2002) 1475-1484
21. Gray T., Nettesheim P., Loftin C., Koo J.S., Bonner J., Peddada S., et al. Interleukin-1β-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol 66 (2004) 337-346
22. Koninger J., Sebastiano P.D., Gardini A., Brigstock D.R., Innocenti P., Buchler M.W., et al. Transforming growth factor-β pathway is activated in cholecystolithiasis. Langenbecks Arch Surg 390 (2005) 21-28
23. Erpecum K.J., Wang D.Q., Moschetta A., Ferri D., Svelto M., Portincasa P., et al. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res 47 (2006) 32-41
24. Schauvliege R., Janssens S., and Beyaert R. Pellino proteins: novel players in TLR and IL-1R signalling. J Cell Mol Med 11 (2007) 453-461
25. Meerarani P., Reiterer G., Toborek M., and Hennig B. The role of PPARgamma signaling in endothelial cell dysfunction induced by linoleic acid. FASEB J 17 (2003) 99